Low level TRIM16 expression in 91 melanoma patient samples, strongly correlated with lymph node metastasis, and, predicted poor patient prognosis in a separate cohort of 170 melanoma patients with lymph node metastasis. This evidence concerns the gene TRIM16 and metastatic malignant neoplasm in the lymph nodes.